man, Broh-Kahn and Mirsky, 1940; Jorpes, 1940; Arquilla and Stavitsky, 1956; Moinat, 1957; Berson and Yalow, 1957 , the central problem concerns the question of whether the insulin molecule has, 19er se, even weak immunogenie properties or whether these properties are related to protein "impurities" contained in commercial preparations.
The experimental work and the first clinical investigations of Schlichtkrull and associates (1968--1972) led to the conclusion that: a) the insulin molecule is not immunogenie; b) the production of antibodies in subjects treated with conventional insulin preparations is not solely due to species differences, but rather to other peptides related to insulin which contaminate the crystalline extracts of beef or pork insulin (mainly the a-and b-Steiner components : Pro-Insulin Like Components and Insulin Like Components).
The term "Monocomponent insulin" (MC-Insulin) is used by Sehlichtkrull, 1972 to designate Sanger's insulin purified from a-and b-components and resolved from e-Steiner's component, to become the sole protein * With the technical assistance of B.C. Brossa, A. Bachiorlini, A. Giolitti. of the preparation "with little or no immunogenic activity when used for therapy". This concept was based on extensive studies in rabbits and humans.
Nevertheless, in the opinion of Fankhauser and associates (1971) , although pork MC-insulins are the ]east immunogenic insulins so far used and the impurities (a-and b-components) are the most prominent factor in the insulin antibody production, the immunogenicity of insulin itself cannot be excluded with full certainty. Furthermore, according to Deekert and Grundah], 1970, pure pig insulin crystals are not immunogenic if injected in a neutral solution corresponding to the ptI of the body fluids.
The purpose of the present investigation was to compare the antigenicity of the Lente prepared from MC-pork insulin (MC Lente or Monotard@) with that of Monospecies, non-monocomponent, Lente prepared from 5 • crystallized, pork insulin (MS Lente) in patients with : a) newly diagnosed insulin-dependent diabetes, never previously treated with insulin; b) long-term, conventionally insulin-treated diabetes presenting clinical conditions such as high insulin requirement, insulin allergy, insulin lipoatrophy, and diabetic mieroangiopathy, which may possibly accompanied by an increased rate of antibody formation.
An additional aim of the investigation was to get information about the quality of clinical control of the diabetes as achieved with MC or MS Lente insulin. Cooperative patients were hospitalized for a fortnight for full examination and therapy. They were on a daily diet of 2000--2500 kcal (20% proteins, 40% fats and 40% carbohydrates) and returned for oncemonthly control after the hospitalization.
Material and Methods

Since
The immunogenicity of the insulin preparations was estimated by determination of:
1. total extractable serum insulin by radioimmunoassay (total IRI) according to I-Ieding (1972) ; normal values: 0--25 ~U/ml; 2. specific insulin-binding capacity of serum IgG (IgG binding) according to the radioimmunoelectrophoresis method of Hein Christiansen (1973) . 30 ~l of a 1-125-pork insulin solution (20 mU/ml, specific activity 20 mCi/mg) was mixed with patient's serum and barbital buffer in equal proportion and incubated overnight at -~4 C. 5 ~1 of the mixture was applied to the holes of an agarose gel plate containing commercial preparation of antihuman IgG from rabbits. The plate was then transferred to the electrophoresis chamber; electrophoresis was run at 2--3 V/cm during 15--20 h. "Cigar-shaped" precipitates containing the insulin bound to the precipitated IgG fraction, were cut out and transferred to a well gamma counter for counting the radioactivity of IgG-bound insulin. Limits of sensitivity: normal sera showed IgG binding values of about 0.05 mU/ml; diabetic sera were accepted as positive at values above 0.10 mU/ml. Autoradiography of the precipitates was used only to get a qualitative evaluation of the presence and location of the tracer of the precipitates. Radioinsulin and antisera were supplied by Novo Research Institute, Copenhagen. This method has proved suitable ranking of the sera for routine clinical purposes (Sch]ichtkrull et al., 1972; Andreani et al., 1972) . As for the binding of Iodinelabelled insulin: cf. Federlin (1971) .
The usual clinical and biochemical data were recorded on standard trial case record sheets: history, age, sex, duration of diabetes, previous treatment, occurrence of other endocrine diseases, fasting blood sugar (true glucose: rag/100 ml), M-value (during hospitalization), urine glucose excretion (g/24 h), proteinuria, ketonuria, body weight, clinical remarks on complications, diet, and the current insulin treatment.
At the beginning of treatment and during periods of readjustment, MC or MS Actrapid insulins were used occasionally as a supplement to or a substitute for the treatment with MC or MS Lente.
Results
Immunological Situation
Group 1: New patients treated with 16--36 Units of MC Lente daily showed, after 300--500 days of treatment, zero or barely detectable IgG insulin binding values (0.05--0.10 mU/ml). In 3 patients, however, IgG binding reached maximal levels of 0.4 mU/ml during the early period of treatment. The total IRI displayed practically the same pattern (Fig. 1) .
Group 2: New patients treated with 12--32 Units of MS Lente daily showed, after the same period of observation, a rise in the IgG binding values above the level of detection up to 1.10 mU/ml, with a corresponding pattern of total IRI (Fig. 2) . Group 3: A marked drop in high initial levels of
IgG binding values was observed in the majority of patients after the transfer from conventional to MC Lente insulin. The high starting levels of total IRI also fell. As Fig. 3 shows, a multiphasic pattern with transient increases --especially in total IRI --is evident in some eases. After about 400 days, values tend to diminish even if not quite to the normal level. Cases with low initial antibody levels, did not have relevant variations at the end of the trial.
Group 4:
In patients treated with conventional insulin and transferred to MS Lente, the levels of IgG binding and total IRI, which were initially high, also tended to decrease, as shown in F/g. d. At various points during the study, however, more or less evident peaks of IgG binding and IRI values were noted. Low IgG binding and total IRI starting levels remained unchanged or presented intercurrent rises of the abovementioned type.
Clinical Situation
The clinical-metabolic control of diabetes after a year or more on MC and MS Lente insulins was rated good in all cases. Fasting blood sugar did not exceed 200 mg/100 ml; glueosuria was within 20--25 g/24 h, except for one case; M-values during hospitalization were under 15--20; ketonuria was generally absent; Diabetologia no episodes of keto-acidosis or hypoglyeaemic shock occurred. Even in cases with a rapid drop in antibody titres, hypoglyeaemia was reported only in the form of mild reactions. Complications such as infections, surgery and pregnancy had no outward effect on the course of the diabetes. An improvement in the subjective state was frequently recorded.
Insulin Lipoatrophy. After a year of treatment with MC Lente there was a complete absence of lipoatrophy in the sites of insulin administration. In two patients there was an almost complete remission of lipoatrophy caused by the previous treatment. One patient experienced a fall in total IRI and IgG binding; the other had low starting antibody levels. before after patient n. patient n. patient n. patient n. patient n. patient n. patient n. patient n. patient n. patient n. patient n. patient n. patient n. patient n. patient n. patient n. patient n. patient n. Group 4: patient n. patient n. patient n. patient n. patient n. patient n. patient n. patient n. patient n. patient n. patient n. patient n. patient n. patient n. No differences were noted in the quality of control between the groups treated with MC and MS Lente insulins.
The following clinical details deserve special consideration because of their possible relation to the immunologieM situation.
Insulin Requirement. No correlation could be established between the behaviour of antibody level and the change in the daily insulin dose. Nevertheless, a reduction in insulin requirement in groups 3 and 4 was possible as shown in Table 1 .
Insulin Allergy. Prior insulin allergy of the immediate local and generalized type disappeared in 3 eases after transfer to MC Lente. A related fall in the serum insulin antibodies was found in 2 cases.
Microangiopathic complications.
A decrease in the serum insulin antibodies was observed in 4 cases. The clinical situation did not, however, present any significant changes.
Conclusions
The following conclusions may be drawn from our preliminary results.
1. The association of the two methods employed (Total II%I and 1-125-IgG binding) seems to be suitable for assessing the level of circulating insulin antibody as a clinical routine.
2. Monocomponent Lente pork insulin was found to be "non immunogenie" in newly diagnosed insulindependent diabetics at the end of a treatment period for more than one year; slight transient antigenie effect was occasionally observed only in the initial phase of therapy. The disappearance or the reduction in the level of circulating antibodies in patients transferred to MC Lente insulin after years of treatment with In comparison to MC Lente insulin, MS Lente insulin seems to possess a slightly greater immunogenie activity.
Our data agree with the preliminary results reported in 37 cases by Korp and Levett (/973) ; and in 48 cases, by Andreani et al. (1972) .
4 conventional insulin preparations agrees with the general impression of an important change in the immunological state. 3. Monospeeies Lente pork insulin appears to be, even if weakly, immunogenie as demonstrated in cases of newly diagnosed insulin-dependent diabetes. In some cases of long-term diabetes, previously treated with conventional insulin preparations, a downward trend in serum antibody levels after transfer to MS Lente was observed. and diabetic mieroangiopathy) was in several instances independent of modifications in the immunological state.
5. A good clinical-metabolic control of diabetes, even in cases of brittle diabetes, very difficult to compensate before the trial, was obtained in nearly all the cases of our series, with a reduction of the daily insulin dose. 
